ClinicalTrials.govpublic full text
Efficacy and Safety of GTR in Comparison to Copaxone®
multiple sclerosis, multiple sclerosis,, relapsing-remitting multiple sclerosis,, glatiramer acetate,, mri,, lesions,, ms relapse rate,, copaxone, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877549
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.